Henry
Hephaestus Pharmaceuticals is a telehealth-focused pharmaceutical company making chronic care affordable and accessible. The Sterile Compounding Pharmacist-in-Charge will lead the sterile compounding pharmacy initiatives and oversee the construction of a sterile compounding facility in Doral, FL. This is a highly visible, on-site leadership role reporting to the Director of Pharmacy Operations with significant impact on business success.
Headquarters
Dover, Delaware, United States
Company Size
201-500 employees
Founded
2022
Henry is an online telehealth service offering personalized care for weight management (GLP-1 and Phentermine programs), women's hormone replacement therapy (HRT), testosterone therapy, and erectile dysfunction. Patients connect with licensed healthcare providers remotely, with no insurance required, and receive prescribed medications shipped directly to their door. All plans include provider visits, medication, supplies, and ongoing care in a single transparent monthly payment with no hidden fees.
Henry Meds Weight Loss Review
Oct 16, 2025
Eli Lilly Sues 4 GLP-1 Telehealth Startups, Escalating War on Knockoff Drugs
Apr 23, 2025
Eli Lilly sues companies selling alternative versions of its weight loss drug : Shots - Health News
Apr 23, 2025
Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Henry.
Apr 23, 2025